Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2002; 40:546-554
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonetti, P. O.
Right arrow Articles by Lerman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonetti, P. O.
Right arrow Articles by Lerman, A.

Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid lowering

Piero O. Bonetti, MD*, Stephanie H. Wilson, MBBS*, Martin Rodriguez-Porcel, MD*, David R. Holmes, Jr, MD, FACC*, Lilach O. Lerman, MD, PhD{dagger} and Amir Lerman, MD, FACC*,*

* Division of Cardiovascular DiseasesRochester, Minnesota, USA
{dagger} Division of Hypertension, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota, USA



View larger version (17K):

[in a new window]
 
Figure 1 (Upper) Anterior wall myocardial perfusion at baseline and in response to intravenous adenosine in the three experimental groups. (Lower) Relative change of anterior wall myocardial perfusion in response to intravenous adenosine in the three experimental groups (compared to baseline). HC = hypercholesterolemic pigs; HC+S = hypercholesterolemic pigs receiving simvastatin; N = normocholesterolemic pigs. *p < 0.01 versus N and HC+S.

 


View larger version (18K):

[in a new window]
 
Figure 2 (Upper) Anterior wall myocardial perfusion at baseline and in response to intravenous dobutamine in the three experimental groups. (Lower) Relative change of anterior wall myocardial perfusion in response to intravenous dobutamine in the three experimental groups (compared to baseline). HC = hypercholesterolemic pigs; HC+S = hypercholesterolemic pigs receiving simvastatin; N = normocholesterolemic pigs. *p < 0.05 vs. N and HC+S.

 


View larger version (15K):

[in a new window]
 
Figure 3 (Upper) Anterior wall microvascular permeability index at baseline and in response to intravenous adenosine in the three experimental groups. (Lower) Relative change of anterior wall microvascular permeability index in response to intravenous adenosine in the three experimental groups (compared to baseline). HC = hypercholesterolemic pigs; HC+S = hypercholesterolemic pigs receiving simvastatin; N = normocholesterolemic pigs. *p < 0.001 vs. N and HC+S.

 


View larger version (15K):

[in a new window]
 
Figure 4 (Upper) Anterior wall microvascular permeability index at baseline and in response to intravenous dobutamine in the three experimental groups. (Lower) Relative change of anterior wall microvascular permeability index in response to intravenous dobutamine in the three experimental groups (compared to baseline). HC = hypercholesterolemic pigs; HC+S = hypercholesterolemic pigs receiving simvastatin; N = normocholesterolemic pigs. *p < 0.05 vs. N.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement